Cibus Global LLC (CBUS)
Healthcare
Biotechnology
1.90 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Cibus Global LLC (CBUS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.9% of the shares are freely tradable; institutional investors hold 33.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
33.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
26.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
74.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
76Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.97 | 11,425,929 | +56.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.78 | 2,118,496 | +0.0 | 03/31/2026 |
| Davidson Kempner Capital Management LP | 2.00 | 1,527,606 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 1.62 | 1,239,364 | +28.8 | 12/31/2025 |
| Vantage Consulting Group Inc. | 1.50 | 1,143,949 | +0.0 | 12/31/2025 |
| Weiss Asset Management LP | 1.16 | 888,124 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 6.61 | 5,045,360 | +0.4 | 04/30/2026 |
| Fidelity Growth Company Fund | 4.46 | 3,403,624 | +0.0 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.10 | 1,602,469 | +0.0 | 04/30/2026 |
| Fidelity Growth Company K6 | 1.28 | 978,064 | -0.3 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.